MedPath

Investigating the effect of early medical treatment with enoxaparin on the rate of successful fertility following assisted reproductive methods

Phase 3
Conditions
Infertility.
Female infertility
Registration Number
IRCT20220530055028N1
Lead Sponsor
Karaj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
80
Inclusion Criteria

Age between 20-40 years
BMI body mass index between 18-30
Having an egg suitable for fertilization
Having a suitable endometrium with a diameter greater than 7 mm

Exclusion Criteria

Not having a specific medical disease that affects the study.
Not taking enoxaparin chronically before the study for any reason
Not having a specific coagulation disease such as platelet deficiency
History of previous abortion
History of successful pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: Serum BhCG level.;Clinical pregnancy. Timepoint: 5 weeks after transfer. Method of measurement: Sonography.
Secondary Outcome Measures
NameTimeMethod
Abortion. Timepoint: Before the 20th week of pregnancy. Method of measurement: Sonography.
© Copyright 2025. All Rights Reserved by MedPath